8-KItem 2.02 · Results of OperationsItem 5.02 · Officer/Director ChangeItem 9.01 · Financial Statements

GE HealthCare reports 5.7% preliminary revenue growth and CFO transition

Filed with the SEC on · Summarized by InvestorsBot

GE HealthCare expects second-quarter 2026 revenue of $5.295 billion, up 5.7% year over year, including 3.5% organic growth, while diluted EPS and adjusted EPS are expected to exceed prior expectations. CFO James (Jay) Saccaro will step down on August 14, 2026, with Controller and Chief Accounting Officer George Newcomb serving as interim CFO; the company reaffirmed its full-year 2026 guidance and will report complete results on July 29.

Read the original filing on SEC EDGAR

Get summaries like this in your inbox every morning

Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.

Subscribe free

More from GE HealthCare Technologies Inc.